Back to Search

MARK STEIN, MD

MD

Medical Oncology Physician

NPI: 1568549319IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

Code: 207RH0000X

215813(NY)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

25MA07779100(NJ)215813(NY)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Education

NEW YORK MEDICAL COLLEGE

Class of 1998

Clinical Trials (6)

6
Linked Trials
1
Recruiting
3
With Results

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

NCT03781752RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR

Sequencing Treatments for Mothers With ADHD and Their At - Risk Children

NCT01816074COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)

NCT02675400COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

NCT00183391COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study

NCT02255565COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)

NCT00663442COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Increased Plasma Concentrations of 6-oxo-Methylphenidate inCarriers Following a Single Oral Dose of Methylphenidate.
PMID 41567292·Med Chem Res·2025
8-other
Sequencing Stimulant Medication and Behavioral Parent Training in Multiplex ADHD Families: A Pilot SMART.
PMID 40009046·J Clin Psychiatry·2025
2-rct
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
PMID 35201607·Cochrane Database Syst Rev·2022
1-meta
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
PMID 32926603·J Clin Psychiatry·2020
4-observational
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
PMID 28647012·J Am Acad Child Adolesc Psychiatry·2017
4-observational
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
PMID 24942409·J Child Psychol Psychiatry·2015
4-observational
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
PMID 17201617·J Child Adolesc Psychopharmacol·2006
8-other
ADHD symptom subtypes in children with pervasive developmental disorder.
PMID 16477513·J Autism Dev Disord·2006
8-other
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
PMID 16275814·Arch Gen Psychiatry·2005
4-observational
Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
PMID 15827573·Neuropsychopharmacology·2005
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Via practice · 2 locations total

Address
195 LITTLE ALBANY ST
NEW BRUNSWICK, NJ 08901

Locations (2)

Practice Location

195 LITTLE ALBANY ST, NEW BRUNSWICK, NJ
(732) 235-2465

Practice Location

161 FORT WASHINGTON AVE FL 9, NEW YORK, NY
(212) 305-5874

Quick Facts

NPI
1568549319
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
2
Years in Practice
28
Clinical Trials
6
Publications
20

Are you this provider?

Claim Your Profile